"Light Adjustable Lens: Evidence, Patient Selection & Practical Guidance" presented by Dr. Tanner J. Ferguson

Learning Objectives: 

  1. Describe the design and mechanism of the light adjustable lens. This includes how UV light from the Light Delivery Device changes lens power, the adjustment range, and the sequence of adjustments and lock-ins.
  2. Identify appropriate candidates for the LAL, including eyes with prior refractive surgery and concomitant pathology. Understand and recognize features that limit outcomes, such as elevated higher-order aberrations, irregular Placido imaging, multiple prior laser vision corrections, and poor dilation.
  3. Apply recent clinical evidence and practical pearls to counsel patients and optimize outcomes. The evidence is the FDA Post-Approval Study vs toric IOLs, the Phase IV registry, and other recently published data. The pearls cover tear film, timing of adjustments, and targeting of LAL

Pre-Presentation Questions: 

  1. What is the labeled adjustment range of the LAL?
    1. ±1.00 D sphere; up to 1.00 D cylinder
    2. −2.00 to +2.00 D sphere; up to 2.00 D cylinder
    3. ±4.00 D sphere; up to 4.00 D cylinder
    4. Sphere only; astigmatism requires a toric LAL
  2. Which best describes the standard adjustment process?
    1. Unlimited adjustments with no lock-in required
    2. Up to 3 adjustments, followed by 2 separate lock-in treatments
    3. One adjustment and one lock-in at the 1-week visit
    4. Adjustments begin on postoperative day 1
  3. Which of the following patients is not an ideal candidate for the LAL?
    1. A 62-year-old with a long history of happy monovision contact lens wear
    2. A 66-year-old with prior myopic LASIK, a well-centered ablation, and regular Placido imaging
    3. A 68-year-old with reduced BCVA from corneal irregularity who relies on a scleral contact lens for their best vision
    4. A 70-year-old who values crisp distance vision and is averse to the risk of glare and halos
Session date: 
10/16/2026 - 8:30am EDT to 12/17/2026 - 11:59pm EST
  • 1.00 AMA PRA Category 1 Credit™

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

  • 1.00 AMA PRA Category 1 Credit™ Participation

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This Live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™ Participation. Learners should claim only credit commensurate with the extent of their participation in the activity.

Please login or register to take this course.
Faculty List: 
Peer reviewer(s)

Daniel Moore, MD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Tanner Ferguson, MD

has a financial relationship (Professional Services) with RxSight;.
has a financial relationship (Professional Services) with Alcon;.
has a financial relationship (Professional Services) with Bausch & Lomb;.
has a financial relationship (Professional Services) with Glaukos;.
has a financial relationship (Professional Services) with Johnson & Johnson;.
has a financial relationship (Professional Services) with Balance Ophthalmics;.
has a financial relationship (Professional Services) with Sight Sciences;.
has a financial relationship (Stock) with Greenman VR;.
has a financial relationship (Stock) with True North CRO;.